What You Need to Know About CBD and Varicose Veins

January 30, 2020 16:00:42

Over the past few years, cannabidiol (CBD) has emerged as one of the most versatile medicines on the market. At least that’s what people say. According to anecdotal evidence and some scientific research, cannabidiol is effective against a variety of conditions, ranging from chronic pain and high blood pressure to insomnia and anxiety. The list is almost endless, and although most of these claims haven’t been scientifically proven yet, a lot of people swear by CBD.

Varicose veins are twisted, enlarged veins. According to the Chicago Vein Institute, there are over 40 million people in the United States suffering from varicose veins. Although their cause is unknown, aging plays a large part in bringing…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.